Managing Hypertension: Because its 2016 with apologies to Justin! Marshall Godwin MD MSc FCFP

Similar documents
ADULT HYPERTENSION PROTOCOL STANFORD COORDINATED CARE

High Blood Pressure (Essential Hypertension)

Management of High Blood Pressure in Adults Based on the Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8)

Vascular Risk Reduction: Addressing Vascular Risk

Hypertension Guidelines

Blood Pressure Assessment Program Screening Guidelines

HYPERTENSION ASSOCIATED WITH RENAL DISEASES

Cardiovascular Risk in Diabetes

Case Study 6: Management of Hypertension

HIGH BLOOD PRESSURE AND YOUR KIDNEYS

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

Treatment of Hypertension: JNC 8 and More

High Blood Pressure and Your Kidneys

High Blood pressure and chronic kidney disease

9/19/2013. Standardizing Preventive Care for Hypertension. About the Speaker. About the Speaker

Hypertension Guideline V4

PRESSURE POINTS SERIES: Introducing high blood pressure

About High Blood Pressure

Guidelines for the management of hypertension in patients with diabetes mellitus

Hypertension and Diabetes

Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence

Measurement of Blood Pressure

Hypertension and Heart Failure Medications. Dr William Dooley

High Blood Pressure and Kidney Disease

High Blood Cholesterol

Board Review: Hypertension Cases

Hypertension Best Practices Symposium

High Blood Pressure and Chronic Kidney Disease. For People With CKD Stages 1 4

High Blood Pressure and Your Kidneys

Easy or complex? University Pharmacy. Pharm.D. candidates, 2011

Blood Pressure. Blood Pressure (mm Hg) pressure exerted by blood against arterial walls. Blood Pressure. Blood Pressure

The Hypertension Treatment Center

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

OEM MAXNIBP Frequently Asked Questions

Absolute cardiovascular disease risk assessment

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Athersclerotic Risk

Special Communication

High Blood Pressure and Chronic Kidney Disease

Case Presentation: Mr. E.M. Dr. Braun

DRUG UTILIZATION EVALUATION OF ANTIHYPERTENSIVE DRUGS IN DIABETIC PATIENTS WITH CKD

JNC-8 Blood Pressure and ACC/AHA Cholesterol Guideline Updates. January 30, 2014

HYPERTENSION MANAGEMENT AND SURVEILLANCE AT PRIMARY CARE LEVEL: A SITUATIONAL ANALYSIS IN THE LIMPOPO PROVINCE

High blood pressure (hypertension)

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

Absolute cardiovascular disease risk management

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Cardiovascular Disease Risk Factors

Primary Care Quality Care Indicators - Accuro EMR Prevention

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

Your Results. For more information visit: Name: Date: In partnership with

Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital

Blood Pressure and Your Health

Antihypertensive Drug Management to Achieve Systolic Blood Pressure <120 mmhg in SPRINT

P R E S S U R E P O I N T S S E R I E S : Measuring your blood pressure at home

Tips and tricks in hypertension

Stroke: Major Public Health Burden. Stroke: Major Public Health Burden. Stroke: Major Public Health Burden 5/21/2012

Listen to your heart: Good Cardiovascular Health for Life

Drug Treatment in Type 2 Diabetes with Hypertension

High Blood Pressure. What Is Blood Pressure?

High Blood Pressure in People with Diabetes:

An Overview and Guide to Healthy Living with Type 2 Diabetes

CASE B1. Newly Diagnosed T2DM in Patient with Prior MI

DIET AND EXERCISE STRATEGIES FOR WEIGHT LOSS AND WEIGHT MAINTENANCE

HEALTH RISK ASSESSMENT (HRS) QUESTIONNAIRE

Epidemiology of Hypertension 陈 奕 希 李 禾 园 王 卓

Heart Failure Outpatient Clinical Pathway

Getting the most from blood pressure medicines

MEDICAL POLICY No R4 BLOOD PRESSURE MONITORS & AMBULATORY BLOOD PRESSURE MONITORING

Isabella Sudano & Franco Muggli

Diabetes and Hypertension Care For Adults in Primary Care Settings

Absolute cardiovascular disease risk

Approaches to the Management of Difficult-to-Control Hypertension

Background (cont) World Health Organisation (WHO) and IDF predict that this number will increase to more than 1,3 million in the next 25 years.

Coronary Heart Disease (CHD) Brief

Assess adherence with medication and lifestyle changes at every opportunity and intervene if necessary

Diabetic Nephropathy

Guidance for Industry Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims

Blood Pressure Medication. Barbara Pfeifer Diabetes Programs Manager

Hypertension and Diabetes Status Bangladesh Demographic and Health Survey

HYPERTENSION: Comparison of New Guidelines

Combination Antihypertensive Therapy: When to use it Diabetes

EXPLORING THE INTERACTION BETWEEN EXERCISE AND MEDICATION FOR CHRONIC DISEASE: CONSIDERATIONS FOR FITNESS PROFESSIONALS

3.5% 3.0% 3.0% 2.4% Prevalence 2.0% 1.5% 1.0% 0.5% 0.0%

Understanding Diseases and Treatments with Canadian Real-world Evidence

Obesity in the United States Workforce. Findings from the National Health and Nutrition Examination Surveys (NHANES) III and

Manitoba EMR Data Extract Specifications

High Blood Pressure. A Guide to Understanding Blood Pressure...

ECG may be indicated for patients with cardiovascular risk factors

How To Treat Dyslipidemia

High Blood Pressure (Hypertension)

Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis

Correspondence to: Rima B Shah (rima_1223@yahoo.co.in) DOI: /ijmsph Received Date: Accepted Date:

THE NHS HEALTH CHECK AND INSURANCE FREQUENTLY ASKED QUESTIONS

Type 2 Diabetes workshop notes

CHEM 1406 BSA/BMI Measurement Laboratory (revised 01/03//06) BSA, Body Surface Area

High blood pressure and stroke

Diabetes Mellitus 1. Chapter 43. Diabetes Mellitus, Self-Assessment Questions

How to measure blood pressure using digital monitors

Chronic Kidney Disease and the Electronic Health Record. Duaine Murphree, MD Sarah M. Thelen, MD

Transcription:

Managing Hypertension: Because its 2016 with apologies to Justin! Marshall Godwin MD MSc FCFP

CFPC CoI Templates: Slide 1 Faculty/Presenter Disclosure Faculty: [Marshall Godwin] Relationships with commercial interests: Grants/Research Support: Only research agency funding CIHR, Heart Stroke, etc. Speakers Bureau/Honoraria: No Consulting Fees: ICEBM International Centre for Evidence Based Medicine payment for critical appraisal of articles. Other: Employee of Memorial University

Part 1: Measurement and Diagnosis Use Automated Office Blood Pressure (AOBP) Devices to diagnosis and follow patients with hypertension 2015 CHEP addresses benefit of AOBP over MOBP Mentions AOBP in their diagnostic algorithm but they don t follow through to the obvious conclusion Perhaps the 2016 will incorporate AOBP more substantially Don t use this, if you can help it

Why Use AOBP rather than MOBP? Uses oscillometric input rather than auditory. Accurate Algorithm Almost completely gets rid of white coat effect. Correlates well with ABPM No need for the 5 minute rest or most of the other caveats.

Auscultatory OBPM is inaccurate In the real world, the accuracy of auscultatory OBPM can be adversely affected by provider, patient and device factors such as: too rapid deflation of the cuff digit preference with rounding off of readings to 0 or 5 also, mercury sphygmomanometers are being phased out and aneroid devices are less likely to remain calibrated Consequence: Routine auscultatory OBPMs are 9/6 mm Hg higher than standardized research BPs (primarily using oscillometric devices) Myers MG, et al. Can Fam Physician 2014;60:127-32. 2015

The Evidence Manual (MOBP) Ausculatory Automated (AOBP) Oscillometric Correlation with Daytime ABPM 0.1 0.6 The sweet-point for sensitivity, specificity and predictive values for AOBP compared to daytime ABPM is 135/85 When using AOBP, definition of high blood pressure is at 135/85 When using MOBP definition of high blood pressure is at 140/90 So all automated devices have a cut-point for elevated at 135/85 -- Home, Daytime ABPM, and AOBP.

Using AOBP in the Office (BpTRU) Feed flat on floor, back resting, arm on desk, right sized cuff 6 readings The first one you watch If all well you leave the room and it does 5 more 1 minute apart is as accurate as 2 minutes apart.

Use of Standardized Measurement Techniques is Recommended when Assessing Blood Pressure When using automated office oscillometric devices such as the BpTRU, the patient should be seated in a quiet room alone. With the device set to take measures at 1 minute intervals, an initial measurement is taken by a health professional to verify that the device is registering a measurement. The patient is left alone after the first measurement and the device automatically takes subsequent readings. 2015

BpTRU $800-$1000 http://www.mantha med.com/officeblood-pressuremonitor.php MicroLife WatchBP Office $300-$400 http://www.microli fe.com/products/ hypertension/prof essional/

BP measurement methods Office Automated (unattended, AOBP) Oscillometric (electronic) http://www.dableducational.org/sphygmomanometers.html http://www.bhsoc.org/bp-monitors/bp-monitors/ 2015

The CHEP Diagnostic Algorithm We ll review what the algorithm says I ll tell you what I do call it a Minority Report (but it actually is what most of the people developing the CHEP guidelines do as far as I can tell.

II. Criteria for the diagnosis of hypertension and recommendations for follow-up: overview Minority Report 3 BpTRU Assessments 2 weeks between assessments All 135/85 Hypertension Combination of elevated ( 135/85 and normal < 135/85) Do 24 hr ABPM All < 135/85 Annual BP measurement Measurement using electronic (oscillometric) upper arm devices is preferred over auscultation ABPM: Ambulatory Blood Pressure Measurement AOBP: Automated Office Blood Pressure HBPM: Home Blood Pressure measurement OBPM: Office Blood Pressure measurement 2015

Missing White Coat Hypertension Important because it results in over-treatment We label and treat people not needing treatment AOBP practically eliminates White Coat Effect Missing Masked Hypertension Important because it results in under-treatment We miss the diagnosis and don t treat when treatment is needed. Single MOBP measurement --- Masked Hypertension 20% Three AOBP assessments Masked Hypertension 4%

CV events per 1000 patient-year The prognosis of white coat and masked hypertension 35 30 25 20 15 CV Events 10 5 0 Normal 23/685 White coat 24/656 Uncontrolled 41/462 Masked 236/3125 Okhubo et al. J. Am. Coll. Cardiol. 2005;46;508-515 2015

Masked hypertension: risk factors high normal clinic BPs older adults males higher BMI smoker excess alcohol consumption diabetes peripheral arterial disease orthostatic hypotension LVH Hanninen MR et al, J Hypertens. 2011;29:1880-88 Barochiner J et al. Am J Hypertens. 2013;28:872-78 Andalib A et al. Intern M ed J. 2012;42:260-66 2015

What to do besides measuring BP Assess potential aggravating factors things that might be causing the BP to be elevated Look for pre-existing end-organ damage Do a Global Cardiovascular Risk Assessment

Assess potential aggravating factors things that might be causing the BP to be elevated NSAIDS, Steroids, OCP Decongestants Antidepressants (MAOI, SSRI, SNRI) Salt Excess alcohol use Stress / Life Circumstances / Anxiety Thyroid Other Cocaine Cyclosporin Licorice Erythropoietin

Look for pre-existing end-organ damage Coronary Artery Disease History, EKG Cerebrovascular Disease History, carotid bruit Peripheral vascular Disease history, physical, ABI, addominal bruit Chronic Kidney Disease. History, Renal function, albuminuria (if diabetic) Retinopathy.. History, physical, ophthalmologist LVH/dysfunction EKG, CXR, Echo Other electrolytes, CBC

Do a Global Cardiovascular Risk Assessment Over 80% of hypertensive Canadians have other cardiovascular risks Abdominal Obesity Dyslipidemia Diabetes or Impaired fasting glucose Sedentary Lifestyle Unhealthy eating Smoking Stress

Do a Global Cardiovascular Risk Assessment Age 55 years Male Family history of premature cardiovascular disease (age <55 in men and < 65 in women)(

Part 2: Management Lifestyle Should Always be part of the Management Plan Accumulation of 30-60 minutes moderate intensity dynamic exercise at least 4 days per week. (walking, running, cycling, swimming) Maintenance of a healthy body weight (body mass index of 18.5 to 24.9, and waist circumference < 102 cm for men and < 88 cm for women) Limit alcohol consumption to 2 drinks per day, and consumption should not exceed 14 standard drinks per week for men and 9 standard drinks per week for women (bottle of beer, 1.5 oz liqueur, 5 oz wine = one standard drink) Diet: Reduce salt intake, DASH Diet, Lots of fruits and veggies. Stress management

Efficacy vs Effectiveness If you do X, then Y will happen = effiacacy If you Exercise, loose weight, eat less salt, drink less alcohol Then your BP will be lower Efficacy X likelihood of adherence = effectiveness Efficacy X likelihood of long-term adherence = long-term effectiveness What proportion of people make significant lifestyle changes resulting in controlling or improving of BP and maintain that lifestyle change for more than a year?

CHEP Says.. Antihypertensive therapy should be prescribed for average DBP measurements of 100 mm Hg (Grade A) or average SBP measurements of 160 mm Hg (Grade A) in patients without macrovascular target organ damage or other cardiovascular risk factors. Antihypertensive therapy should be strongly considered if DBP readings average 90 mm Hg in the presence of macrovascular target organ damage or other independent cardiovascular risk factors (Grade A).? Antihypertensive therapy should be strongly considered if SBP readings average 140 mm Hg in the presence of macrovascular target organ damage (Grade C for 140-160 mm Hg; Grade A for > 160 mm Hg).? Antihypertensive therapy should be considered in all patients meeting indications 1-3 in this section, regardless of age (Grade B). Caution should be exercised in elderly patients who are frail. In the very elderly (age 80 years) patients who do not have diabetes or target organ damage, the SBP threshold for initiating drug therapy is 160 mm Hg (Grade C) (revised recommendation).

Minority Report Approach. If Hypertension is diagnosed based on CHEP (or Minority Report) Criteria Treat First try Lifestyle only for 3-6 Months followed by medications if not effective (Regardless of BP, other Risk Factors, or Target Organ damage) Speed and Intensity of treatment based on BP level, Risk Factors, Target Organ Damage Target <140/90 (<135/85 on BpTRU) If the patient is age 80 or over and doesn t have target organ involvement or diabetes when hypertension diagnosed, take your time. Overzealous treatment probably more harmful than the elevated blood pressure. Target <160 systolic

Choice of Therapy for Adults with Hypertension Without Compelling Indications for Specific Agents Initial therapy should be monotherapy with a thiazide/thiazide-like diuretic (Grade A), a β-blocker (in patients younger than 60 years, Grade B), an ACE inhibitor (in nonblack patients, Grade B), a long-acting calcium channel blocker (CCB) (Grade B); or an ARB (Grade B). Additional antihypertensive drugs should be used if target BP levels are not achieved with standard-dose monotherapy (Grade B). Add-on drugs should be chosen from first-line choices. Can start with two drugs if sbp > 20 above target or dbp > 10 above target

My approach to this following CHEP recommendations Thiazide ACE/ARB CCB (dihydropyridine) Hydrochlorothiazide Chlorthalidone indapamide Ramipril Lisinopril Perindopril Many Others Candesartan Losartan Valsartan Others Amlodipine Nifedipine Felodipine BB Metoprolol Many Others Start with One (usually HCTZ) and move to mid-range dose Add second and move to mid-range dose Add third and move to mid-range dose Go back and increase each to max or near-max dose in steps If on three at max/near max dose and still not controlled then WHY?

Example: 50 year old Caucasian man with BpTRU average 155/98 after three readings. Overweight, likes salt, works at a desk, doesn't work out. Nonsmoker. Some stress. Tries to deal with lifestyle issues and after 6 months has lost 4 pounds, walks 2-3 times a week. BPTRU still 150/94. HCTZ 12.5mg HCTZ 25mg Ramipril 5mg Ramipril 10mg Amlodipine 5mg Amlodipine 10mg 4 th Drug Referral? Secondary Hypertension Adherence Salt Other meds WHY? Ramipril 20mg

Caveats Avoid Beta Blockers in people over 60 unless also needed for IHD Don t use ACEI and ARB together. Don t use ACEI in black patients. Short acting Nifedipine should not be used. Try not to drop diastolic BP below 60 in people with CAD ACE and BB as initial Rx in people with CAD or CHF Use ARB if ACE not tolerated. Non-diabetic kidney disease target <140/90 (<135/85 for AOBP) Diabetics target is <130/80 Diabetics should be on an ACE or ARB then CCB rather than thiazide